{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:35:17Z","timestamp":1773916517642,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T00:00:00Z","timestamp":1386547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082034","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T21:32:54Z","timestamp":1386624774000},"page":"e82034","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Kuo-How","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Lin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Lin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Chiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Ting","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Kang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Tso","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hsun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shing-Hwa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.urology.2009.09.051","article-title":"Bladder cancer detection, treatment and outcomes: opportunities and challenges","volume":"75","author":"DM Latini","year":"2010","journal-title":"Urology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1200\/JCO.1985.3.11.1463","article-title":"Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study","volume":"3","author":"WG Harker","year":"1985","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5347(17)42494-3","article-title":"M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium","volume":"139","author":"CN Sternberg","year":"1988","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.2001.19.4.1229","article-title":"Gemcitabine and cisplatin for advanced, metastatic bladder cancer","volume":"19","author":"MH Cohen","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"H von der Maase","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00310-6","article-title":"Targeting cyclooxygenase-2 in human neoplasia: rationale and promise","volume":"4","author":"AJ Dannenberg","year":"2003","journal-title":"Cancer Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/1535-7163.MCT-07-0313","article-title":"Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells","volume":"7","author":"D Dhawan","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref9","volume":"174","unstructured":"Dovedi SJ, Kirby JA, Atkins H, Davies BR, Kelly JD (2005) Cyclooxygenase-2 inhibition: a potential mechanism for increasing the efficacy of bacillus calmette-guerin immunotherapy for bladder cancer. J Urol <volume>174<\/volume>: : 332\u2013337; discussion 337."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-03-1086","article-title":"Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1\/cip1 and p27kip1 and cell cycle arrest","volume":"64","author":"C Han","year":"2004","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2003.12.014","article-title":"Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"67","author":"TJ Maier","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"ref12","first-page":"471","article-title":"Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer","volume":"15","author":"J Gee","year":"2006","journal-title":"Oncol Rep"},{"key":"ref13","first-page":"5599","article-title":"Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats","volume":"60","author":"CJ Grubbs","year":"2000","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biopha.2008.04.007","article-title":"In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells","volume":"63","author":"J Qin","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1158\/0008-5472.CAN-08-1642","article-title":"OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma","volume":"68","author":"M Gao","year":"2008","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e33615","DOI":"10.1371\/journal.pone.0033615","article-title":"Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells","volume":"7","author":"KH Huang","year":"2012","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/auto.6.2.11124","article-title":"Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells","volume":"6","author":"S Huang","year":"2010","journal-title":"Autophagy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.02-0947fje","article-title":"Celecoxib activates a novel mitochondrial apoptosis signaling pathway","volume":"17","author":"V Jendrossek","year":"2003","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/jnci\/djh322","article-title":"Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells","volume":"96","author":"X Liu","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/1535-7163.MCT-06-0629","article-title":"Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib","volume":"6","author":"P Pyrko","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"G Kroemer","year":"2010","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1158\/0008-5472.CAN-07-1462","article-title":"Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation","volume":"67","author":"K Sato","year":"2007","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/auto.3269","article-title":"Role of autophagy in cancer: management of metabolic stress","volume":"3","author":"S Jin","year":"2007","journal-title":"Autophagy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-07-1595","article-title":"The roles of therapy-induced autophagy and necrosis in cancer treatment","volume":"13","author":"RK Amaravadi","year":"2007","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"ref25","first-page":"3221","article-title":"Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines","volume":"20","author":"TC Hour","year":"2000","journal-title":"Anticancer Res"},{"key":"ref26","first-page":"608","article-title":"Characterization of a newly established human bladder carcinoma cell line, NTUB1","volume":"91","author":"HJ Yu","year":"1992","journal-title":"J Formos Med Assoc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcp.2011.03.026","article-title":"UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity","volume":"82","author":"AM Huang","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bcp.2010.04.007","article-title":"Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells","volume":"80","author":"TC Hour","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ejmech.2011.01.043","article-title":"Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS","volume":"46","author":"JH Cheng","year":"2011","journal-title":"Eur J Med Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.foodchem.2012.04.133","article-title":"Cytotoxic and antioxidant constituents from Garcinia subelliptica","volume":"135","author":"KW Lin","year":"2012","journal-title":"Food Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.toxlet.2013.04.021","article-title":"Dual inhibitor of phosphoinositide 3-kinase\/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux","volume":"220","author":"JR Li","year":"2013","journal-title":"Toxicol Lett"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1593\/neo.10110","article-title":"Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells","volume":"12","author":"PC Lee","year":"2010","journal-title":"Neoplasia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ijc.2910110327","article-title":"Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen","volume":"11","author":"J Bubenik","year":"1973","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"B Levine","year":"2008","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e17412","DOI":"10.1371\/journal.pone.0017412","article-title":"Starvation induced cell death in autophagy-defective yeast mutants is caused by mitochondria dysfunction","volume":"6","author":"SW Suzuki","year":"2011","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/auto.6.1.10326","article-title":"Control of basal autophagy by calpain1 mediated cleavage of ATG5","volume":"6","author":"HG Xia","year":"2010","journal-title":"Autophagy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/auto.1.2.1858","article-title":"Structure-function relationship of Atg12, a ubiquitin-like modifier essential for autophagy","volume":"1","author":"T Hanada","year":"2005","journal-title":"Autophagy"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Y Kabeya","year":"2000","journal-title":"The EMBO journal"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","article-title":"Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis","volume":"10","author":"K Degenhardt","year":"2006","journal-title":"Cancer Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Y Kabeya","year":"2000","journal-title":"EMBO J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1242\/jcs.01131","article-title":"LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation","volume":"117","author":"Y Kabeya","year":"2004","journal-title":"J Cell Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2008.07.005","article-title":"Endoplasmic reticulum stress and autophagy as targets for cancer therapy","volume":"275","author":"AH Schonthal","year":"2009","journal-title":"Cancer Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1073\/pnas.79.6.1889","article-title":"3-Methyladenine: specific inhibitor of autophagic\/lysosomal protein degradation in isolated rat hepatocytes","volume":"79","author":"PO Seglen","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","first-page":"343","article-title":"Cell death induced by nutritional starvation in mouse macrophage-like RAW264.7 cells","volume":"29","author":"H Sakagami","year":"2009","journal-title":"Anticancer research"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"B Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/sj.cdd.4401765","article-title":"Autophagy: molecular machinery for self-eating","volume":"12","author":"T Yorimitsu","year":"2005","journal-title":"Cell death and differentiation"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"JM Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/auto.3653","article-title":"Endoplasmic reticulum stress: a new pathway to induce autophagy","volume":"3","author":"T Yorimitsu","year":"2007","journal-title":"Autophagy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"30299","DOI":"10.1074\/jbc.M607007200","article-title":"Endoplasmic reticulum stress triggers autophagy","volume":"281","author":"T Yorimitsu","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor","volume":"38","author":"NM Davies","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-09-0788","article-title":"Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward","volume":"16","author":"DG Menter","year":"2010","journal-title":"ClinCancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/00912700022008766","article-title":"Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial","volume":"40","author":"PT Leese","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"ref53","first-page":"6045","article-title":"Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models","volume":"60","author":"CS Williams","year":"2000","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:49:00Z","timestamp":1746071340000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082034"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,9]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082034","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,9]]}}}